Simon Graspeuntner

Dr. Simon Graspeuntner is a researcher at the Department of Infectious Diseases and Microbiology (KIM) within the Faculty of Medicine at the University of Lübeck, affiliated with University Hospital Schleswig-Holstein (UKSH). He serves as a key member of the Rupp/Tholey research group (Project P8) focused on cultivating and characterizing microbes relevant to inflammatory bowel disease (IBD) and infant microbiome dynamics.

His research spans Microbiology, Infectious Diseases, and Microbiome Research, with specialized expertise in neonatal gut colonization, antibiotic resistance mechanisms, and bacterial proteomics. He employs advanced culturomics and proteomic techniques to analyze species like Blautia producta and Bacteroides thetaiotaomicron, investigating how medical interventions (e.g., cesarean sections, antimicrobial prophylaxis) impact microbial ecosystem development in infants.

Analysis of his 2018-2023 publications reveals consistent focus on clinical-microbiological intersections: neonatal microbiome establishment, dysbiosis preceding sepsis in preterms, and diagnostic innovations for sexually transmitted infections. His work bridges clinical observations with laboratory characterization of bacterial physiology under varying environmental conditions.

Supported by the German Research Foundation (DFG), Dr. Graspeuntner collaborates extensively with the Christian-Albrechts-Universität zu Kiel, Research Center Borstel, Helmholtz Munich (HMGU), and the Max Planck Institute for Evolutionary Biology through multi-institutional projects addressing critical gaps in infectious disease diagnostics and microbiome science.